Medical Equipment

Ventracor Limited (ASX:VCR) Announce Results of US Feasibility Trial of the VentraAssist LVAD

🕔4/14/2008 12:56:20 PM

Ventracor Limited (ASX:VCR)(US:VTCRY) today released the clinical results of the US Feasibility Trial of the VentrAssist(R) Left Ventricular Assist Device (LVAD). The results were presented on Saturday 12 April at the annual meeting of the International Society of Heart and Lung Transplantation (ISHLT) in Boston by Dr. Andrew Boyle, Assistant Professor of Medicine at the University of Minnesota Medical School, in Minneapolis MN.

Read Full Article▸

Ventracor Limited (ASX:VCR) CEO Peter Crosby Letter to Shareholders

🕔4/3/2008 1:55:54 PM

Ventracor Limited (ASX: VCR)(PNK: VTCRY) CEO, Peter Crosby Letter to Shareholders

Read Full Article▸

Advanced Surgical Design and Manufacturer's (ASX: AMT) Pad Implant Featured on ABC Science Program "Catalyst"

🕔4/3/2008 12:35:31 PM

Leading Australian developer and manufacturer of prosthetic implants and medical devices, Advanced Surgical Design and Manufacture Limited (ASX: AMT) announces that this Thursday's episode of Catalyst (ABC TV) will feature the Limb Saving clinical trial currently being undertaken by AllVascular Pty Ltd and utilising the PAD access device developed with Advanced Surgical and exclusively manufactured by Advanced Surgical.

Read Full Article▸

Ventracor Limited (ASX:VCR) Announce Election of John Ward to Chairman

🕔4/3/2008 10:51:25 AM

Ventracor Limited (ASX: VCR)(PNK: VTCRY) announced today changes to the Board of Directors. John Massey has retired as a Director and Chairman of the Board. John Ward has been elected Chairman of the Board of Directors, and William Curran takes on the role of Chairman of the Audit, Risk and Compliance Committee.

Read Full Article▸

Ventracor (ASX:VCR) Announce US FDA Unconditional Approval of Destination Therapy Trial For LVAD

🕔3/17/2008 9:52:43 AM

Ventracor Limited (ASX: VCR)(ADR: VTCRY) announced today that the US Food and Drug Administration (FDA) has granted unconditional approval for the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).

Read Full Article▸

Ventracor Limited (ASX:VCR) Appoints Destination Therapy Trial Principal Investigator For LVAD

🕔3/13/2008 11:13:21 AM

Ventracor (ASX: VCR) announced today the appointment of Professor Mariell Jessup as Cardiology Principal Investigator of the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).

Read Full Article▸

Ellex Medical Lasers (ASX:ELX) Announce Revenues Up 19% - Audio Cast

🕔2/26/2008 3:22:30 PM

Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced its financial results for the half year ended 31 December 2007. The result demonstrated strong, continuous growth in the business with revenues growing 19% over the prior comparable period.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines